Ad
related to: fda
Search results
FDA report highlights need to improve diversity in clinical trials
Clinical Trials Arena via Yahoo Finance· 60 minutes agoThe US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is...
Cervical cancer self-test is a gamechanger for women’s health
WBAY Green Bay· 9 minutes agoWomen have a new way to check for cervical cancer, and it’s groundbreaking. The FDA approved the first self-test for cervical cancer. Cervical cancer kills about 4,000 women ...
Throw out COVID-19 tests made by Cue Health, FDA warns
WPIX New York City, NY via Yahoo News· 2 hours agoCue Health, headquartered in San Diego, received emergency use FDA authorization for two COVID-19...
FDA said it never inspected dental lab that made controversial AGGA device
The State· 4 hours agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the Anterior Growth Guidance Appliance, or "AGGA," a dental device that has allegedly ...
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Zacks via Yahoo Finance· 2 days agoPhilips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power...
FDA approves self-collection screening for virus that causes cervical cancer - The Boston Globe
The Boston Globe· 15 hours ago“It provides women who might not have otherwise had the opportunity — or inclination — to get...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 21 hours agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
FDA Broadens Breyanzi's Follicular Lymphoma Indication
Medscape· 7 hours agoThe overall response rate to the CAR T therapy was 95.7% in phase 2 testing.
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Benzinga via Yahoo Finance· 18 hours agoTuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for...